Found: 11
Select item for more details and to access through your institution.
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 393, doi. 10.1007/s00432-018-2800-8
- By:
- Publication type:
- Article
TNF-α Blocker Effect of Naringenin-Loaded Sericin Microparticles that Are Potentially Useful in the Treatment of Psoriasis.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 8, p. 13624, doi. 10.3390/ijms150813624
- By:
- Publication type:
- Article
Glycolipids carrying Le.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 2, p. 225, doi. 10.1002/ijc.2910510210
- By:
- Publication type:
- Article
An Eco-Friendly Enantioselective Access to ( R)-Naringenin as Inhibitor of Proinflammatory Cytokine Release.
- Published in:
- Chemistry & Biodiversity, 2013, v. 10, n. 8, p. 1531, doi. 10.1002/cbdv.201200227
- By:
- Publication type:
- Article
The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
- Published in:
- Skeletal Muscle, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13395-021-00273-6
- By:
- Publication type:
- Article
Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat.
- Published in:
- Molecular Medicine, 2013, v. 19, n. 1, p. 79, doi. 10.2119/molmed.2013.00011
- By:
- Publication type:
- Article
Inhibition of HDAC Activity by ITF2357 Ameliorates Joint Inflammation and Prevents Cartilage and Bone Destruction in Experimental Arthritis.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 5/6, p. 391, doi. 10.2119/molmed.2011.00058
- By:
- Publication type:
- Article
Pharmacokinetics, Safety and Inducible Cytokine Responses during a Phase 1 Trial of the Oral Histone Deacetylase Inhibitor ITF2357 (Givinostat).
- Published in:
- Molecular Medicine, 2011, v. 17, n. 5/6, p. 353, doi. 10.2119/molmed.2011.00020
- By:
- Publication type:
- Article
ITF1697, a Stable Lys-Pro--Containing Peptide, Inhibits Weibel-Palade Body Exocytosis Induced by Ischemia/Reperfusion and Pressure Elevation.
- Published in:
- Molecular Medicine, 2007, v. 13, n. 11/12, p. 615, doi. 10.2119/2007-00079.Bertuglia
- By:
- Publication type:
- Article
Chiral Flavanones from Amygdalus lycioides Spach: Structural Elucidation and Identification of TNFalpha Inhibitors by Bioactivity-guided Fractionation.
- Published in:
- Molecules, 2012, v. 17, n. 2, p. 1665, doi. 10.3390/molecules17021665
- By:
- Publication type:
- Article